Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
GT Biopharma Inc (OP: GTBP)
0.1500 USD  -0.0030 (-1.96%)
Official Closing Price  /  Updated: 3:51 PM EDT, Apr 2, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 14,795
Open 0.1520
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1530
Today's Range 0.1420 - 0.1520
52wk Range 0.0650 - 0.6000
Shares Outstanding 50,117,977
Dividend Yield N/A
Performance
YTD
+52.28%
+52.28%
1 Month
+53.06%
+53.06%
3 Month
+52.28%
+52.28%
6 Month
+4.90%
+4.90%
1 Year
-51.57%
-51.57%
Top News
More News
GT Biopharma Announces Commencement of Retreatment of Patient Demonstrating Successful Clinical Benefit following GTB-3550 TriKE(TM) therapy
from ACCESSWIRE
UPDATE: GT Biopharma Announces Preliminary Results for GTB-3550 TriKE(TM) Phase I/II Clinical Trial for Treatment of Acute Myeloid Leukemia
from ACCESSWIRE
More News
Read More
GT Biopharma Announces Preliminary Results for GTB-3550 TriKE(TM) Phase I/II Clinical Trial for Treatment of Acute Myeloid Leukemia
from ACCESSWIRE
GT Biopharma and Cytovance Biologics Announce Collaboration Agreement TriKE(TM) Therapeutic for Treatment of Coronavirus Infection
from ACCESSWIRE
GT Biopharma Announces Dosing First Patient In GTB-3550 TriKE(TM) Phase I/II Clinical Trial
from ACCESSWIRE
GT Biopharma Provides Update Concerning Trike(TM) Drug Development Programs and Other Strategic Initiatives
from ACCESSWIRE
GT Biopharma Announces Solid Tumor Targeting TriKe™ Kills
from PR Newswire
GT Biopharma Announces HIV TriKE™ Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
from PR Newswire
GT Biopharma Announces HIV Trike™ Data to be Published
from PR Newswire
GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to DAS Therapeutics
from PR Newswire
University of Minnesota discovery is now a first-in-human clinical trial for leukemia
from GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.